Oversubscribed financing co-led by HealthCap and EQT Life Sciences (formerly LSP); joined by Pureos Bioventures
Developing novel drugs for systemic targeted radiation therapy (STRT)
Proceeds will be used to advance lead radiopharmaceutical product,…
Establishment of BlueRock site in Berlin expands company’s footprint and strengthens Bayer’s cell therapy capabilities / Acceleration of the development of cell therapies in BlueRock’s pipeline, with initial focus on the ongoing BRT-DA01 clinical…
HONOURING LIFE-TIME ACHIEVEMENTS TOWARDS HEALTH FOR ALL
The evaluation of complex data, for example from high-throughput experiments or the sequencing of genomes – in short: Computational Biology – provides valuable insights in medicine, biotechnology and pharmacology and has become indispensable in…
Hein to lead as SCIENION plans for long-term profitable growth
EPO has been founded in 1997 as a spin-off from the Max-Delbrück-Center for Molecular Medicine [MDC] in Berlin Buch and is celebrating its 25th business anniversary this year. Since 1997 EPO has grown steadily and today has a loyal customer base of…
BERLIN, BOSTON, REYKJAVIK, 05 May 2022 – International digital therapeutics leader Sidekick Health (www.sidekickhealth.com) today announces that it has raised $55 million in Series B funding. The round was led by London-based venture capital firm N…
On May 11, 2022 the 16. Speed Lecture Award at BIONNALE took place in the Urania Berlin in front of 450 participants on site and 700 participants via livestream. The best speakers were voted by the audience.
The start-up challenge connects top notch start-ups and manufacturing companies to increase manufacturing efficiency and sustainability together - at the Bits&Pretzels in Munich
MiGenTra and ProBioGen announce the appointment of Dr. Lutz Hilbrich, Chief Executive Officer of both companies, as Senator to the Senate of Economy Europe. The certificate of appointment was presented to Dr. Hilbrich in Strasbourg, France, today.
…